Bobby Reddy Jr
Chicago, United States
Bobby Reddy, Jr., Ph.D. is Co-Founder and CEO of Prenosis, a biologically driven technology company that develops and implements integrated diagnostic-therapeutic products in acute care to improve patient outcomes. Since founding Prenosis in 2016, Bobby has led the company to achieve significant milestones, including the groundbreaking FDA marketing authorization of Sepsis ImmunoScore™ in April 2024, the first-ever FDA-authorized AI diagnostic tool for sepsis, recognized as one of TIME's Best Inventions of 2024. Previously, Bobby served as Research Scientist at the University of Illinois at UrbanaChampaign, developing electrical point-of-care biosensors and managing strategic partnerships with Taiwan Semiconductor Manufacturing Company, Abbott Diagnostics, and Intel. Bobby holds a Ph.D. in Electrical Engineering from UIUC, an M.S. and B.S. in Electrical Engineering and a B.S. in Computer Engineering from UC Irvine. Named to Crain's Chicago Business 40 Under 40, his mission is "to see people diƯerently – to tailor healthcare to each individual's biology.
